Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 1,267 results.

Thumbnail for Safety and Feasibility of the CALGB 10403 Pediatric-Inspired Regimen in Adults With Acute Lymphoblastic Leukemia Older Than 40 Years

ALL - 588

Safety and Feasibility of the CALGB 10403 Pediatric-Inspired Regimen in Adults With Acute Lymphoblastic Leukemia Older Than 40 Years

Manuel Alejandro Cruz-Martinez

Poster Presenter: Manuel Alejandro Cruz-Martinez

Thumbnail for Olverembatinib Combined With Blinatumomab in Patients With Lymphoid Blast Phase Chronic Myeloid Leukemia (CML-LBP) or Philadelphia Chromosome e-Positive B-Cell Precursor Acute Lymphoblastic Leukemia (Ph+ BCP-ALL)

ALL - 589

Olverembatinib Combined With Blinatumomab in Patients With Lymphoid Blast Phase Chronic Myeloid Leukemia (CML-LBP) or Philadelphia Chromosome e-Positive B-Cell Precursor Acute Lymphoblastic Leukemia (Ph+ BCP-ALL)

Elias Jabbour

Poster Presenter: Elias Jabbour

Previous 1...43 44 45 46 47 48 49...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Navigating the WHO-HEAM5 Lymphoma Landscape: An Imaging Primer for Hematologists

ABCL - 590

Navigating the WHO-HEAM5 Lymphoma Landscape: An Imaging Primer for Hematologists

Ahmed Salem

Poster Presenter: Ahmed Salem

Thumbnail for Acute Organ Dysfunction Burden as a Predictor of In-Hospital Mortality in Leukemia Hospitalizations: A National Inpatient Sample Analysis (2018-2023)

AML - 591

Acute Organ Dysfunction Burden as a Predictor of In-Hospital Mortality in Leukemia Hospitalizations: A National Inpatient Sample Analysis (2018-2023)

Ramsha Khan

Poster Presenter: Ramsha Khan

Thumbnail for Clinical Predictors of In-Hospital Mortality Among Patients Hospitalized With Acute Myeloid Leukemia: A National Inpatient Sample Analysis (2018-2023)

AML - 592

Clinical Predictors of In-Hospital Mortality Among Patients Hospitalized With Acute Myeloid Leukemia: A National Inpatient Sample Analysis (2018-2023)

Ramsha Khan

Poster Presenter: Ramsha Khan

$Thumbnail for Phase 3, Randomized Study of Talquetamab (Tal) Plus Daratumumab (Dara) ± Pomalidomide (Pom) vs Dara Plus Pom and Dexamethasone (DPd) in Relapsed/Refractory Multiple Myeloma (RRMM): MonumenTAL-3$

MM - 593

Phase 3, Randomized Study of Talquetamab (Tal) Plus Daratumumab (Dara) ± Pomalidomide (Pom) vs Dara Plus Pom and Dexamethasone (DPd) in Relapsed/Refractory Multiple Myeloma (RRMM): MonumenTAL-3

Omik Patel

Poster Presenter: Omik Patel

Thumbnail for Clinical Overview of Infection Events With Orca-T vs Conventional Allogeneic Hematopoietic Stem Cell Transplantation in the Precision-T Phase 3 Study

CT - 594

Clinical Overview of Infection Events With Orca-T vs Conventional Allogeneic Hematopoietic Stem Cell Transplantation in the Precision-T Phase 3 Study

Roni Tamari

Poster Presenter: Roni Tamari

Thumbnail for Predictors of In-Hospital Mortality Among Patients Hospitalized With Chronic Myeloid Leukemia: A National Inpatient Sample Analysis (2018-2023)

CML - 596

Predictors of In-Hospital Mortality Among Patients Hospitalized With Chronic Myeloid Leukemia: A National Inpatient Sample Analysis (2018-2023)

Ramsha Khan

Poster Presenter: Ramsha Khan

Thumbnail for Updated Results of POLARIS-1 (Part 1), a Global Registrational Phase 3 Study: Olverembatinib Combined With Low-Intensity Chemotherapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

ALL - 597

Updated Results of POLARIS-1 (Part 1), a Global Registrational Phase 3 Study: Olverembatinib Combined With Low-Intensity Chemotherapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Suning Chen

Poster Presenter: Suning Chen

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors